Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-01-05 @ 9:17 PM
Study NCT ID:
NCT03291158
Status:
WITHDRAWN
Last Update Posted:
2023-09-21
First Post:
2017-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
Sponsor:
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MDCO-MIN-16-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None